PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2017Expert Opinion on Drug Delivery58 citations

A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice

View Full Paper
TBTimothy S. BaileyJSJenine Y. Stone

Key Points

  • To assess the effectiveness of the Bluetooth-enabled insulin delivery system in improving dosing accuracy and adherence among diabetes patients.
  • Developed InPen system with Bluetooth connectivity and mobile application integration.
  • Conducted formative testing and usability studies to evaluate system performance.
  • Reviewed existing technologies for insulin delivery and bolus advice.
  • User feedback indicated improved confidence in dosing decisions with the InPen system.
  • Significant reduction in dosing errors noted compared to traditional methods.
  • Demonstrated potential for enhanced glucose control in insulin pen users.

Abstract

INTRODUCTION: Diabetes is growing in prevalence internationally. As more individuals require insulin as part of their treatment, technology evolves to optimize delivery, improve adherence, and reduce dosing errors. Insulin pens outperform vial and syringe in simplicity, dosing accuracy, and user preference. Bolus advisors improve dosing confidence and treatment adherence. The InPen System offers a novel approach to treatment via a wireless pen that syncs to a mobile application featuring a bolus advisor, enabling convenient insulin dose tracking and more accurate bolus advice among other features. Areas covered: Existing technology for insulin delivery and bolus advice are reviewed. The mechanics and functionality of the InPen device are delineated. Findings from formative testing and usability studies of the InPen system are reported. Future directions for the InPen system in the treatment of diabetes are discussed. Expert opinion: Diabetes management is complex and largely data-driven. The InPen System offers a promising new opportunity to avail insulin pen-users of features known to improve treatment efficacy, which have otherwise primarily been available to those using pumps. Given that the majority of insulin users do not use insulin pumps, the InPen System is poised to improve glucose control in a significant portion of the diabetes population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bailey et al. (2017) studied this question.

synapsesocial.com/papers/6a0e1d1a358c8502d7d08f42https://doi.org/10.1080/17425247.2017.1313831
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Insulin Pens 2.0: Innovations, Challenges, and Patient-Centered Perspectives2025
  2. 2Smart Insulin Pen: Managing Insulin Therapy for People with Diabetes in the Digital Era2023
  3. 3Leveraging the Internet of Medical Things (IoMT) in Diabetes Care: A Review of Smart Insulin Pen Innovations2026 · 1 citations
  4. 4Connected Insulin Pens and Pen Caps: Expanding Diabetes Technology Access and Adoption2025
  5. 5Decision-support for functional insulin therapy on multiple daily injections: an integrated qualitative study of patients and healthcare professionals2026